Breaking News

You are here » Indian-Commodity  :  Top News  :  Lupin concludes USFDA inspection at Pithampur facility without any observations

29-Jul2017

Lupin concludes USFDA inspection at Pithampur facility without any observations

Lupin has successfully completed GMP inspection as well as a PAI inspection (Prior Approval Inspection) carried out by the United States Food and Drug Administration (USFDA) at its Pithampur manufacturing facility - Unit 1 without any observations. The inspection which started on July 24, 2017 concluded on July 28, 2017.

Earlier, USFDA had successfully completed PAI at company's Goa manufacturing facility without any observations. The inspection which started on July 17 concluded on July 21, 2017.

Lupin is an innovation led transnational pharmaceutical company developing and delivering a wide range of branded & generic formulations, biotechnology products and APIs globally.




Related News

View all news

Crude oil futures end lower on Friday

Crude oil futures ended lower on Friday on concerns about global energy demand. However, US prices managed to tally a gain for the week, their third in a row, as OPEC output cuts and US sanctions on Venezuela......

Gold futures finish higher on Friday

Gold futures finished higher on Friday, due to increased safe haven buying of market participants followed by subdued economic data from the euro zone, exacerbating global growth fears. Gold futures for......

Copper futures end lower on global growth concerns

Copper futures ended lower on Friday as weak European and US factory data spread gloom about the global economic outlook and strengthened the dollar. Reports showing Factory activity in the 19-country......

Top News

View all news

Infosys to enter into agreement with The House Fund II

Infosys is going to enter into an agreement with The House Fund II, L.P., an AI-focused fund targeting startups from the University of California - Berkeley, committing to invest $10.0 million.......

EID Parry receives approval for investment Rs 70 crore in PSRIPL

EID Parry (INDIA) has received approval for investment upto Rs 70 crore in the equity share capital of Parry Sugars Refinery India (PSRIPL), a wholly owned subsidiary of the Company. The Board of directors......

SBI raises Rs 1,251 crore by issuing Basel III-compliant bonds

State Bank of India (SBI) has raised Rs 1,251.30 crore by issuing Basel III-compliant bonds. The Committee of Directors for Capital Raising at its meeting held on 22 March 2019 deliberated and accorded......